Drug
Sea Bcma
Sea Bcma: highest development phase Phase 1, developed by Seagen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Seagen
Trials
| Drug | Phase | Indication |
|---|---|---|
| SEA-BCMA NCT03582033 | Phase 1 | Multiple Myeloma |
Latest
No recent events.
Follow Sea Bcma on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.